Acceptability of human papillomavirus immunization

Gregory Zimet, Rose M. Mays, Yvette Winston, Romina Kee, James Dickes, Ling Su

Research output: Contribution to journalArticle

144 Citations (Scopus)

Abstract

The purpose of this study was to examine the attitudes about hypothetical human papillomavirus (HPV) vaccines in two groups of women in clinical settings. Twenty adolescent women attending an urban community adolescent health clinic and 20 adult women attending a city health department sexually transmitted disease (STD) clinic were recruited to participate in individual interviews. Adolescents were 14-18 years of age (mean 15.6), 75% non-Hispanic white, and 75% sexually experienced. Adults were 20-50 years of age (mean 33.6), 95% African American, and all were sexually experienced. As part of the interview, participants ranked nine hypothetical HPV vaccines in order of acceptability. Each vaccine was uniquely defined as a function of cost ($150, $50, or free), efficacy (50% or 90%), disease targeted (genital warts, cervical cancer, or both), and physician recommendation (not mentioned by a physician or specifically recommended). Rankings by adolescents and adults were highly concordant (Spearman rho = 0.9). Efficacy, physician's recommendation, and cost influenced rankings most strongly. Ranking decisions were often based on complex decision making, in which all characteristics were considered simultaneously. These findings suggest that certain features of an HPV vaccine might significantly affect vaccine acceptability. Vaccine efficacy, physician endorsement, and cost were particularly salient issues.

Original languageEnglish
Pages (from-to)47-50
Number of pages4
JournalJournal of Women's Health and Gender-Based Medicine
Volume9
Issue number1
DOIs
StatePublished - Jan 2000

Fingerprint

Papillomavirus Vaccines
Immunization
Physicians
Vaccines
Costs and Cost Analysis
Interviews
Condylomata Acuminata
Sexually Transmitted Diseases
Uterine Cervical Neoplasms
African Americans
Decision Making
Health

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Acceptability of human papillomavirus immunization. / Zimet, Gregory; Mays, Rose M.; Winston, Yvette; Kee, Romina; Dickes, James; Su, Ling.

In: Journal of Women's Health and Gender-Based Medicine, Vol. 9, No. 1, 01.2000, p. 47-50.

Research output: Contribution to journalArticle

Zimet, Gregory ; Mays, Rose M. ; Winston, Yvette ; Kee, Romina ; Dickes, James ; Su, Ling. / Acceptability of human papillomavirus immunization. In: Journal of Women's Health and Gender-Based Medicine. 2000 ; Vol. 9, No. 1. pp. 47-50.
@article{86508ae92132416da008e52ece1107b8,
title = "Acceptability of human papillomavirus immunization",
abstract = "The purpose of this study was to examine the attitudes about hypothetical human papillomavirus (HPV) vaccines in two groups of women in clinical settings. Twenty adolescent women attending an urban community adolescent health clinic and 20 adult women attending a city health department sexually transmitted disease (STD) clinic were recruited to participate in individual interviews. Adolescents were 14-18 years of age (mean 15.6), 75{\%} non-Hispanic white, and 75{\%} sexually experienced. Adults were 20-50 years of age (mean 33.6), 95{\%} African American, and all were sexually experienced. As part of the interview, participants ranked nine hypothetical HPV vaccines in order of acceptability. Each vaccine was uniquely defined as a function of cost ($150, $50, or free), efficacy (50{\%} or 90{\%}), disease targeted (genital warts, cervical cancer, or both), and physician recommendation (not mentioned by a physician or specifically recommended). Rankings by adolescents and adults were highly concordant (Spearman rho = 0.9). Efficacy, physician's recommendation, and cost influenced rankings most strongly. Ranking decisions were often based on complex decision making, in which all characteristics were considered simultaneously. These findings suggest that certain features of an HPV vaccine might significantly affect vaccine acceptability. Vaccine efficacy, physician endorsement, and cost were particularly salient issues.",
author = "Gregory Zimet and Mays, {Rose M.} and Yvette Winston and Romina Kee and James Dickes and Ling Su",
year = "2000",
month = "1",
doi = "10.1089/152460900318957",
language = "English",
volume = "9",
pages = "47--50",
journal = "Journal of Women's Health",
issn = "1540-9996",
publisher = "Mary Ann Liebert Inc.",
number = "1",

}

TY - JOUR

T1 - Acceptability of human papillomavirus immunization

AU - Zimet, Gregory

AU - Mays, Rose M.

AU - Winston, Yvette

AU - Kee, Romina

AU - Dickes, James

AU - Su, Ling

PY - 2000/1

Y1 - 2000/1

N2 - The purpose of this study was to examine the attitudes about hypothetical human papillomavirus (HPV) vaccines in two groups of women in clinical settings. Twenty adolescent women attending an urban community adolescent health clinic and 20 adult women attending a city health department sexually transmitted disease (STD) clinic were recruited to participate in individual interviews. Adolescents were 14-18 years of age (mean 15.6), 75% non-Hispanic white, and 75% sexually experienced. Adults were 20-50 years of age (mean 33.6), 95% African American, and all were sexually experienced. As part of the interview, participants ranked nine hypothetical HPV vaccines in order of acceptability. Each vaccine was uniquely defined as a function of cost ($150, $50, or free), efficacy (50% or 90%), disease targeted (genital warts, cervical cancer, or both), and physician recommendation (not mentioned by a physician or specifically recommended). Rankings by adolescents and adults were highly concordant (Spearman rho = 0.9). Efficacy, physician's recommendation, and cost influenced rankings most strongly. Ranking decisions were often based on complex decision making, in which all characteristics were considered simultaneously. These findings suggest that certain features of an HPV vaccine might significantly affect vaccine acceptability. Vaccine efficacy, physician endorsement, and cost were particularly salient issues.

AB - The purpose of this study was to examine the attitudes about hypothetical human papillomavirus (HPV) vaccines in two groups of women in clinical settings. Twenty adolescent women attending an urban community adolescent health clinic and 20 adult women attending a city health department sexually transmitted disease (STD) clinic were recruited to participate in individual interviews. Adolescents were 14-18 years of age (mean 15.6), 75% non-Hispanic white, and 75% sexually experienced. Adults were 20-50 years of age (mean 33.6), 95% African American, and all were sexually experienced. As part of the interview, participants ranked nine hypothetical HPV vaccines in order of acceptability. Each vaccine was uniquely defined as a function of cost ($150, $50, or free), efficacy (50% or 90%), disease targeted (genital warts, cervical cancer, or both), and physician recommendation (not mentioned by a physician or specifically recommended). Rankings by adolescents and adults were highly concordant (Spearman rho = 0.9). Efficacy, physician's recommendation, and cost influenced rankings most strongly. Ranking decisions were often based on complex decision making, in which all characteristics were considered simultaneously. These findings suggest that certain features of an HPV vaccine might significantly affect vaccine acceptability. Vaccine efficacy, physician endorsement, and cost were particularly salient issues.

UR - http://www.scopus.com/inward/record.url?scp=0034113349&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034113349&partnerID=8YFLogxK

U2 - 10.1089/152460900318957

DO - 10.1089/152460900318957

M3 - Article

VL - 9

SP - 47

EP - 50

JO - Journal of Women's Health

JF - Journal of Women's Health

SN - 1540-9996

IS - 1

ER -